|
| << previous | next >> |
Journal description
All volumes of the corresponding journal
All issues of the corresponding volume
All articles of the corresponding issues
Details for article 15 of 30 found articles
| Title: |
Model-informed drug development approach supporting approval of the 4-week (Q4W) dosing schedule for nivolumab (Opdivo) across multiple indications: a regulatory perspective |
| Author: |
Bi, Y. Liu, J. Furmanski, B. Zhao, H. Yu, J. Osgood, C. Ward, A. Keegan, P. Booth, B.P. Rahman, A. Wang, Y. |
| Appeared in: |
Annals of oncology |
| Paging: | Volume 30 () nr. 4 pages 644-651 |
| Year: |
2019 |
| Contents: | |
| Publisher: |
Published by Elsevier B.V. |
| Source file: |
Elektronische Wetenschappelijke Tijdschriften |
Details for article 15 of 30 found articles
| << previous | next >> |